Circulating Activated Protein C inSubjects with Heterozygous Gln506-Factor V

Publisher： Karger

E-ISSN： 1424-8840|28|1|31-36

ISSN： 1424-8832

Source： Pathophysiology of Haemostasis and Thrombosis, Vol.28, Iss.1, 1999-01, pp. : 31-36

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Factor V Is an Anticoagulant Cofactor for Activated Protein C during Inactivation of Factor Va

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 37, Iss. 1, 2010-05 ,pp. : 17-23

Karger

Access to resources Recommend Favorite

Response to Activated Protein C in Subjects with and without Dementia

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 28, Iss. 3-4, 1999-06 ,pp. : 209-215

Karger

Access to resources Recommend Favorite

Renal transplantation experience in a patient with factor V Leiden homozygous, MTHFR C677T heterozygous, and PAI heterozygous mutation

By  

PEDIATRIC TRANSPLANTATION, Vol. 19, Iss. 5, 2015-08 ,pp. : E126-E129

John Wiley & Sons Inc

Access to resources Recommend Favorite

Resistance to Activated Protein C, Factor V Leiden and the Prothrombin G20210A Variant in Patients with Colorectal Cancer

By  

Pathophysiology of Haemostasis and Thrombosis, Vol. 32, Iss. 1, 2002-05 ,pp. : 2-7

Karger

Access to resources Recommend Favorite

Recombinant Factor VII (Activated) for Haemorrhagic Complications of Severe Sepsis Treated with Recombinant Protein C (Activated)

By  

Acta Haematologica, Vol. 116, Iss. 2, 2006-08 ,pp. : 126-130

Karger

Access to resources Recommend Favorite